Severe relapse of epilepsy after vigabatrin withdrawal: for how long should we treat symptomatic infantile spasms?
Kröll-Seger
Judith
J
Kaminska
Anna
A
Moutard
Marie Laure
ML
de Saint-Martin
Anne
A
Guët
Agnes
A
Dulac
Olivier
O
Chiron
Catherine
C
D002540:Cerebral Cortex / Q000002:abnormalities; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D012008:Recurrence; D018570:Risk Assessment; D012720:Severity of Illness Index; D013036:Spasms, Infantile / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D013997:Time Factors; D020888:Vigabatrin / Q000009:adverse effects* / Q000627:therapeutic use
D020888:Vigabatrin